The POZOLIB brand, founded in 2013 (United States), from 9 sister brands and 2214 competing brands. POZOLIB is owned by Incyte Co., listed on the stock exchange of New York POZOLIB belongs to the Biotechnology business sector.

POZOLIB is a brand of Incyte Co. (INCY) Share price

International deposit : 2013 Business sector Biotechnology

Share price and profitability of the share Incyte Co. (POZOLIB)

Buy Incyte Co. share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested USD 51.74

Portfolio valuation
Incyte Co. (POZOLIB) over 5 years* USD 35.96

Stock market history Incyte Co. (POZOLIB)

*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances

Other brands
Incyte Co.

See more brands of Incyte Co.

Rival brands
POZOLIB

NOTABLE LABS
NOTABLE LABS
Roivant
Roivant
Valerio Therapeutics
Valerio Therapeutics
INVERSAGO
INVERSAGO
Terns Pharma
Terns Pharma
Vaxcyte
Vaxcyte
OTHER RIVAL BRANDS

Top Popularity Web

See the full ranking
Desirable brands that generate Pricing Power and therefore stock market performance
Desirable brands that generate Pricing Power and therefore stock market performance

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more
MORE NEWS